KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Other Non-Current Liabilities (2017 - 2025)

Neogenomics (NEO) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $12.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 2.52% year-over-year to $12.1 million, compared with a TTM value of $12.1 million through Dec 2025, up 2.52%, and an annual FY2025 reading of $12.1 million, up 2.52% over the prior year.
  • Other Non-Current Liabilities was $12.1 million for Q4 2025 at Neogenomics, up from $12.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $14.4 million in Q3 2021 and bottomed at $3.7 million in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $12.0 million, with a median of $13.0 million recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities dropped 12.47% in 2021, then surged 281.47% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $14.0 million in 2021, then fell by 6.9% to $13.1 million in 2022, then dropped by 0.16% to $13.0 million in 2023, then dropped by 9.68% to $11.8 million in 2024, then increased by 2.52% to $12.1 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NEO at $12.1 million in Q4 2025, $12.0 million in Q3 2025, and $12.1 million in Q2 2025.